Cengild Medical Bhd (XKLS:0243) Debt-to-EBITDA : 0.65 (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Cengild Medical Bhd Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Cengild Medical Bhd's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was RM1.38 Mil. Cengild Medical Bhd's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was RM12.56 Mil. Cengild Medical Bhd's annualized EBITDA for the quarter that ended in Mar. 2024 was RM21.62 Mil. Cengild Medical Bhd's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 was 0.64.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Cengild Medical Bhd's Debt-to-EBITDA or its related term are showing as below:

XKLS:0243' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.7 Med: 1.85 Max: 24.31
Current: 0.71

During the past 6 years, the highest Debt-to-EBITDA Ratio of Cengild Medical Bhd was 24.31. The lowest was 0.70. And the median was 1.85.

XKLS:0243's Debt-to-EBITDA is ranked better than
74.88% of 430 companies
in the Healthcare Providers & Services industry
Industry Median: 2.54 vs XKLS:0243: 0.71

Cengild Medical Bhd Debt-to-EBITDA Historical Data

The historical data trend for Cengild Medical Bhd's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cengild Medical Bhd Debt-to-EBITDA Chart

Cengild Medical Bhd Annual Data

Trend

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Debt-to-EBITDA

Get a 7-Day Free Trial

4.35

2.45

1.24

0.93

0.70

Cengild Medical Bhd Quarterly Data
	Jun18	Jun19	Jun20	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-EBITDA	Get a 7-Day Free Trial										0.71	1.01	0.65	0.72	0.65

Competitive Comparison of Cengild Medical Bhd's Debt-to-EBITDA

For the Medical Care Facilities subindustry, Cengild Medical Bhd's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cengild Medical Bhd's Debt-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Cengild Medical Bhd's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Cengild Medical Bhd's Debt-to-EBITDA falls into.

Cengild Medical Bhd Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Cengild Medical Bhd's Debt-to-EBITDA for the fiscal year that ended in Jun. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(1.331	+	13.602)	/	21.278
	=	0.70

Cengild Medical Bhd's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(1.377	+	12.564)	/	21.62
	=	0.64

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Mar. 2024) EBITDA data.

Cengild Medical Bhd (XKLS:0243) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Cengild Medical Bhd Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Cengild Medical Bhd's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Cengild Medical Bhd (XKLS:0243) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Cengild Medical Bhd (XKLS:0243) » Definitions » Debt-to-EBITDA

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.7, Jalan Kerinchi, Unit 2-3 & 2-4, Level 2, Nexus, Bangsar South, Kuala Lumpur, MYS, 59200

Website

https://www.cengild.com

Cengild Medical Bhd is a healthcare service provider operating a medical centre specialising in the diagnosis and treatment of gastrointestinal related oncology and gynaecology services., liver diseases and obesity. The company operates in Malaysia and has two reportable segments, Consultant Services and Medical Management Services. A substantial portion of the overall revenue is generated from its Medical Management Services segment.

Cengild Medical Bhd (XKLS:0243) Headlines

No Headlines